ARDELYX, INC.

ARDX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.7B · 489 employees
209
SEC Filings
$3.42
Close 2026-09-18
489
Employees

Business Summary

Ardelyx is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative medicines. It markets two FDA-approved therapies based on tenapanor, an NHE3 inhibitor: IBSRELA for irritable bowel syndrome with constipation (IBS-C) in adults, and XPHOZAH to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company also has a pipeline including a Phase 3 trial for CIC and a next-generation NHE3 inhibitor program (RDX10531).

Latest Stock Quote

ARDX 2026-09-18 $3.42 O:$3.38 H:$3.445 L:$3.33 Vol:6.4M VWAP:$3.4028
origin leaf: null

Next Earnings

expected 2026-11-16

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-192025-12-310001437402-26-000013EDGAR75K words
2025-02-202024-12-310001628280-25-006653EDGAR71K words
2024-02-222023-12-310001628280-24-006393EDGAR83K words
2023-03-022022-12-310001628280-23-006041EDGAR85K words
2022-02-282021-12-310001628280-22-004226EDGAR—
2021-03-082020-12-310001558370-21-002500EDGAR—
2020-03-062019-12-310001558370-20-002138EDGAR—
2019-03-062018-12-310001558370-19-001583EDGAR—
2018-03-142017-12-310001558370-18-002056EDGAR—
2017-02-172016-12-310001193125-17-047972EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001437402-26-000044EDGAR50K words
2025-10-302025-09-300001437402-25-000018EDGAR45K words
2025-08-042025-06-300001628280-25-037464EDGAR45K words
2025-05-012025-03-310001628280-25-021516EDGAR42K words
2024-10-312024-09-300001628280-24-044551EDGAR54K words
2024-08-012024-06-300001628280-24-034121EDGAR52K words
2024-05-022024-03-310001628280-24-019990EDGAR50K words
2023-10-312023-09-300001628280-23-035597EDGAR55K words
2023-08-022023-06-300001628280-23-026569EDGAR54K words
2023-05-032023-03-310001628280-23-015212EDGAR52K words
2022-11-032022-09-300001628280-22-028180EDGAR—
2022-08-042022-06-300001628280-22-021047EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-170001193125-26-354026EDGAR0K words
2026-08-060001437402-26-000043EDGAR3K words
2026-02-190001437402-26-000012EDGAR3K words
2026-01-080001437402-26-000003EDGAR1K words
2025-12-170001437402-25-000021EDGAR1K words
2025-10-300001437402-25-000016EDGAR3K words
2025-10-140001437402-25-000008EDGAR1K words
2025-08-040001628280-25-037441EDGAR3K words
2025-07-030001628280-25-034132EDGAR33K words
2025-06-180001628280-25-032172EDGAR1K words

209 total filings indexed. 177 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

irritable-bowel-syndrome-with-constipation-(ibs-c) chronic-kidney-disease-(ckd)-on-dialysis-/-hyperphosphatemia chronic-idiopathic-constipation-(cic) gastrointestinal-specialty nephrology-specialty nhe3-inhibition-mechanism paracellular-phosphate-absorption-inhibition esrd-prospective-payment-system-(medicare)

Company Identity

CIK0001437402
TickerARDX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.ardelyx.com
Listed2014-06-19

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 8a40a1dd0b88c0e20d9b486db730e221f1fcf2821487a97df80268fc01b0b3de
parent: d8dfc4b25625e19d70b0915608e24b8d2a8d7233677b238e41f786749ed6d0a9
content hash: 956da1bd4f0b619d124c2940be6e5cf5a4a2bc7296b00cb49c667e9ddc4e0149
signed: 2026-09-29T19:00:19.117Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ARDX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ARDX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ARDX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.